Structural genomic abnormalities of chromosomes 9 and 18 in myxopapillary ependymomas

Journal of Neuropathology and Experimental Neurology

Volumn 62, Issue 9, 2003, Pages 927-935

  Mahler Araujo, Maria Betania ^b   Sanoudou, Despina ^b   Tingby, Ola ^b   Liu, Lu ^b   Coleman, Nicholas ^b   Ichimura, Koichi ^b   Collins, Vincent Peter ^a  

^a ADDENBROOKE S HOSPITAL   (United Kingdom)

^b NONE

Author keywords

Aneusomy; Central nervous system tumors; Comparative genomic hybridization; Fluorescence in situ hybridization; Microsatellite analysis; Polysomy

Indexed keywords

MICROSATELLITE DNA;

ADULT; AGED; ALLELISM; ARTICLE; AUTOPSY; CENTRAL NERVOUS SYSTEM TUMOR; CENTROMERE; CHROMOSOME 10; CHROMOSOME 11; CHROMOSOME 13; CHROMOSOME 17Q; CHROMOSOME 18; CHROMOSOME 20; CHROMOSOME 22; CHROMOSOME 3; CHROMOSOME 4; CHROMOSOME 7; CHROMOSOME 8; CHROMOSOME 9; CLINICAL ARTICLE; COMPARATIVE GENOMIC HYBRIDIZATION; EPENDYMOMA; FEMALE; FLUORESCENCE IN SITU HYBRIDIZATION; GENE STRUCTURE; HUMAN; HUMAN TISSUE; MALE; MOLECULAR PROBE; PATHOGENESIS; POLYSOME; PRIORITY JOURNAL;

EID: 0141566755     PISSN: 00223069     EISSN: None     Source Type: Journal    
DOI: 10.1093/jnen/62.9.927     Document Type: Article

References (34)

1. Kernohan JW. Primary tumors of the spinal cord and intradural filum terminale. In: Penfield W, ed. Cytology and cellular pathology of the nervous system. Vol. 3. New York: Hoeber, 1932:993
2. Kleihues P, Cavenee WK. Pathology and genetics. Tumours of the nervous system. Lyon: IARC, 2000
3. Woesler B, Moskopp D, Kuchelmeister K, Schul C, Wassmann H. Intracranial metastasis of a spinal myxopapillary ependymoma. A case report. Neurosurg Rev 1998;21:62-65
4. Ross DA, McKeever PE, Sandler HM, Muraszko KM. Myxopapillary ependymoma. Results of nucleolar organizing region staining. Cancer 1993;71:3114-18
5. Bardales RH, Porter MC, Sawyer JR, Mrak RE, Stanley MW. Metastatic myxopapillary ependymoma: Report of a case with fine-needle aspiration findings. Diagn Cytopathol 1994;10:47-53
6. Sawyer JR, Crowson ML, Roloson GJ, Chadduck WM. Involvement of the short arm of chromosome 1 in a myxopapillary ependymoma. Cancer Genet Cytogenet 1991;54:55-60
7. Bhattacharjee MB, Armstrong DD, Vogel H, Cooley LD. Cytogenetic analysis of 120 primary pediatric brain tumors and literature review. Cancer Genet Cytogenet 1997;97:39-53
8. Sawyer JR, Miller JP, Ellison DA. Clonal telomeric fusions and chromosome instability in a subcutaneous sacrococcygeal myxopapillary ependymoma. Cancer Genet Cytogenet 1998;100:169-75
9. Kindblom LG, Lodding P, Hagmar B, Stenman G. Metastasizing myxopapillary ependymoma of the sacrococcygeal region. A clinico-pathologic, light- and electronmicroscopic, immunohistochemical, tissue culture, and cytogenetic analysis of a case. Acta Pathol Microbiol Immunol Scand [A] 1986;94:79-90
10. Griffin CA, Long PP, Carson BS. Brem H. Chromosome abnormalities in low-grade central nervous system tumors. Cancer Genet Cytogenet 1992;60:67-73
11. Scheil S, Bruderlein S, Eicker M, et al. Low frequency of chromosomal imbalances in anaplastic ependymomas as detected by comparative genomic hybridization. Brain Pathol 2001;11:133-43
12. Reardon DA, Entrekin RE, Sublett J, et al. Chromosome arm 6q loss is the most common recurrent autosomal alteration detected in primary pediatric ependymoma. Genes Chromosomes Cancer 1999;24:230-37
13. Jeuken JW, Sprenger SH, Gilhuis J, Teepen HL, Grotenhuis AJ, Wesseling P. Correlation between localization, age, and chromosomal imbalances in ependymal tumours as detected by CGH. J Pathol 2002;197:238-44
14. Carter M, Nicholson J, Ross F, et al. Genetic abnormalities detected in ependymomas by comparative genomic hybridisation. Br J Cancer 2002;86:929-39
15. Lamszus K, Lachenmayer L, Heinemann U, et al. Molecular genetic alterations on chromosomes 11 and 22 in ependymomas. Int J Cancer 2001;91:803-8
16. Kraus JA, de Millas W, Sorensen N, et al. Indications for a tumor suppressor gene at 22q11 involved in the pathogenesis of ependymal tumors and distinct from hSNF5/INI1. Acta Neuropathol (Berl) 2001;102:69-74
17. Ebert C, von Haken M, Meyer-Puttlitz B, et al. Molecular genetic analysis of ependymal tumors. N-F2 mutations and chromosome 22q loss occur preferentially in intramedullary spinal ependymomas. Am J Pathol 1999;155:627-32
18. Ichimura K, Schmidt EE, Goike HM, Collins VP. Human glioblastomas with no alterations of the CDKN2A (p16INK4A, MTS1) and CDK4 genes have frequent mutations of the retinoblastoma gene. Oncogene 1996;13:1065-72
19. Brustle O, Ohgaki H, Schmitt HP, Walter GF, Ostertag H, Kleihues P. Primitive neuroectodermal tumors after prophylactic central nervous system irradiation in children. Association with an activated K-ras gene. Cancer 1992;69:2385-92
20. Kallioniemi A, Kallioniemi OP, Sudar D, et al. Comparative genomic hybridization for molecular cytogenetic analysis of solid tumors. Science 1992;258:818-21
21. Telenius H, Carter NP, Bebb CE, Nordenskjold M, Ponder BA, Tunnacliffe A. Degenerate oligonucleotide-primed PCR: General amplification of target DNA by a single degenerate primer. Genomics 1992;13:718-25
22. Ried T, Heselmeyer-Haddad K, Blegen H, Schrock E, Auer G. Genomic changes defining the genesis, progression, and malignancy potential in solid human tumors: A phenotype/genotype correlation. Genes Chromosomes Cancer 1999;25:195-204
23. Gebhart E, Liehr T. Patterns of genomic imbalances in human solid tumors (Review). Int J Oncol 2000;16:383-99
24. Koschny R, Koschny T, Froster UG, Krupp W, Zuber MA. Comparative genomic hybridization in glioma: A meta-analysis of 509 cases. Cancer Genet Cytogenet 2002;135:147-59
25. Burton EC, Lamborn KR, Feuerstein BG, et al. Genetic aberrations defined by comparative genomic hybridization distinguish long-term from typical survivors of glioblastoma. Cancer Res 2002;62:6205-10
26. Liu L, Ichimura K, Pettersson EH, Collins VP. Chromosome 7 rearrangements in glioblastomas; loci adjacent to EGFR are independently amplified. J Neuropathol Exp Neurol 1998;57:1138-45
27. Mazewski C, Soukup S, Ballard E, Gotwals B, Lampkin B. Karyotype studies in 18 ependymomas with literature review of 107 cases. Cancer Genet Cytogenet 1999;113:1-8
28. Vagner-Capodano AM, Zattara-Cannoni H, Gambarelli D, et al. Cytogenetic study of 33 ependymomas. Cancer Genet Cytogenet 1999;115:96-99
29. Neumann E, Kalousek DK, Norman MG, Steinbok P, Cochrane DD, Goddard K. Cytogenetic analysis of 109 pediatric central nervous system tumors. Cancer Genet Cytogenet 1993;71:40-49
30. Granzow M, Popp S, Weber S, et al. Isochromosome 1q as an early genetic event in a child with intracranial ependymoma characterized by molecular cytogenetics. Cancer Genet Cytogenet 2001;130:79-83
31. Hirose Y, Aldape K, Bollen A, et al. Chromosomal abnormalities subdivide ependymal tumors into clinically relevant groups. Am J Pathol 2001;158:1137-43
32. Grill J, Avet-Loiseau H, Lellouch-Tubiana A, et al. Comparative genomic hybridization detects specific cytogenetic abnormalities in pediatric ependymomas and choroid plexus papillomas. Cancer Genet Cytogenet 2002;136:121-25
33. Ward S, Harding B, Wilkins P, et al. Gain of 1q and loss of 22 are the most common changes detected by comparative genomic hybridisation in paediatric ependymoma. Genes Chromosomes Cancer 2001;32:59-66
34. Zheng PP, Pang JC, Hui AB, Ng HK. Comparative genomic hybridization detects losses of chromosomes 22 and 16 as the most common recurrent genetic alterations in primary ependymomas. Cancer Genet Cytogenet 2000;122:18-25